# 490MO Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) in Chinese patients with breast cancer susceptibility gene (BRCA) altered metastatic castration-sensitive prostate cancer (mCSPC): Subgroup analysis of the phase III AMPLITUDE trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/490mo-niraparib-nira-and-abiraterone-acetate-plus-prednisone-aap-in-chinese/

## Facts

| Field | Value |
| --- | --- |
| Author Names | B. Wang,D. Ye,H. Guo,L. Li,Suneel Mundle,F. Shen,Anildeep Singh,Y. Liu,Xiaoyu Jia,L. Han,N. Chen,H. Luo |
| Citations | 0 |
| DOI | 10.1016/j.annonc.2025.10.385 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W7116873453 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Xiaoyu Jia](https://scholariq.org/researchers/xiaoyu-jia/)
- [Suneel Mundle](https://scholariq.org/researchers/suneel-mundle/)
- [Anildeep Singh](https://scholariq.org/researchers/anildeep-singh/)
- [H. Guo](https://scholariq.org/researchers/h-guo/)
- [H. Luo](https://scholariq.org/researchers/h-luo/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.